WuXi AppTec Co., Ltd. - SIC # 8740 -

Ticker Exchange SIC # Website Latest Ticker
WUXAY Over the counter 8740 www.wuxiapptec.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for WuXi AppTec Co., Ltd.

Alibaba Under Review: Pentagon Flags Chinese Tech Giants in Military Link Assessment - Dec 2nd, 2025 4:11 am
Pentagon Cited Alibaba on China Military Aid in Oct. 7 Memo - Nov 27th, 2025 2:04 am
Alibaba, BYD, Baidu trade lower on Pentagon’s China military ties report - Nov 26th, 2025 12:08 pm
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry - Nov 19th, 2025 7:00 pm
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Award in the CRDMO Industry - Nov 19th, 2025 5:00 pm
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health - Oct 28th, 2025 3:00 am
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance - Oct 26th, 2025 1:53 am
Fresh China-US Trade Tensions Undercut Asian Stock Markets - Oct 13th, 2025 4:37 am
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends - Sep 21st, 2025 6:00 pm
China's healthcare sector sees record US$10.6 billion fundraising as biotech booms - Sep 10th, 2025 3:30 am
WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year - Sep 8th, 2025 6:00 am
WuXi AppTec Completes Second RMB1.0 Billion A-Share Repurchase Program in 2025, All Repurchased Shares to Be Cancelled - Aug 27th, 2025 6:00 pm
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year - Aug 5th, 2025 6:00 pm
North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace - Jul 29th, 2025 2:06 am
WuXi AppTec Achieves Strong Growth in Revenue and Profit for Q2 and H1 2025, H1 Revenue from Continuing Operations[1] Up 24.2% YoY, and Adjusted Non-IFRS Net Profit Up 44.4% YoY; Backlog for Continuing Operations Up 37.2% YoY - Jul 28th, 2025 3:48 am
Earnings, Trade Outlooks Mute Asian Stock Markets - Jul 11th, 2025 4:38 am
WuXi AppTec Issues Positive Profit Alert for the First Half of 2025 - Jul 10th, 2025 6:00 pm
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities - Jul 7th, 2025 8:41 pm
WuXi AppTec Receives MSCI ESG AAA Leader Rating - Jul 7th, 2025 6:08 am
WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity - Jun 26th, 2025 6:00 pm